<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2C711771-B8F6-4CDF-9AC3-9FAB317463D9"><gtr:id>2C711771-B8F6-4CDF-9AC3-9FAB317463D9</gtr:id><gtr:name>University of Cape Town</gtr:name><gtr:address><gtr:line1>Private Bag</gtr:line1><gtr:line2>Rondebosch</gtr:line2><gtr:postCode>7700</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/030E1F0B-A0CC-46CC-AAB2-60E0AE70713D"><gtr:id>030E1F0B-A0CC-46CC-AAB2-60E0AE70713D</gtr:id><gtr:firstName>Nicaise</gtr:firstName><gtr:surname>Ndembi</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B5C2A8F2-DAD6-4AEE-BDAC-381A0037E9C5"><gtr:id>B5C2A8F2-DAD6-4AEE-BDAC-381A0037E9C5</gtr:id><gtr:firstName>Pontiano</gtr:firstName><gtr:surname>Kaleebu</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U950092728"><gtr:id>016DCF20-296A-4BAE-A32D-82275FDE9ACB</gtr:id><gtr:title>Basic Science Programme / HIV dual infection studies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U950092728</gtr:grantReference><gtr:abstractText>The immune system of individuals infected with the human immunodeficiency virus (HIV), the virus that causes AIDS, usually reacts with the development of immune cells and the production of antibodies that are directed against HIV. This immune reaction does not normally protect the infected individual from disease, but it may potentially protect the patient from infection with another strain of HIV (super infection). In Africa, it is not known how often infection with two different strains of HIV occurs (dual infection), and to what extent this dual infection happens simultaneously or subsequently (after development of an immune response against the first strain). The information is of interest from epidemiological, virological and immunological points of view, and may be important in the context of designing an effective HIV vaccine.</gtr:abstractText><gtr:technicalSummary>The project aims to develop and apply new assays to detect inter- and intra- subtype dual infection (both simultaneous co-infection and consecutive super-infection) to determine the prevalence of dual infection within the population of the Rural Clinical Cohort.||Based on archived blood samples from HIV infected participants of the Rural Clinical Cohort (RCC) in Masaka District and of the Good Health for Women Project (GHWP) in Kampala, the Heteroduplex Mobility Assay (HMA), molecular cloning and viral sequencing will be employed to identify and study specimens from this cohort that show dual HIV infection and infection with recombinant viruses. Single genome amplified (SGA) env-V1-V4 genes will be used to map recombination breakpoints with the help of SimPlot software. The RCC is an open cohort that has been established at one of MRC Uganda s field stations and followed for 20 years. The GHWP is a cohort of women at high risk of HIV recruited in a red light area of Kampala.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-07-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1048358</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Alabama at Birmingham</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Dual and superinfection studies</gtr:description><gtr:id>459A8532-8A99-4827-B5F0-D5738B4433BC</gtr:id><gtr:impact>Training
Supervision
External funding</gtr:impact><gtr:outcomeId>iM3mBTNQDnx-2</gtr:outcomeId><gtr:partnerContribution>Training
Supervision of studentsTraining
Supervision of students
Paper manuscripts</gtr:partnerContribution><gtr:piContribution>Generation of ideas and Proposal writting
Looking for external funding
Supervision</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cape Town</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Dual and superinfection studies</gtr:description><gtr:id>650981AC-ABEF-4D0A-9F9A-9F358AD5BE60</gtr:id><gtr:impact>Training
Supervision
External funding</gtr:impact><gtr:outcomeId>iM3mBTNQDnx-1</gtr:outcomeId><gtr:partnerContribution>Training
Supervision of studentsTraining
Supervision of students
Paper manuscripts</gtr:partnerContribution><gtr:piContribution>Generation of ideas and Proposal writting
Looking for external funding
Supervision</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dual infection</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E0EC97C4-AC94-407A-87FE-EB36A7D78D84</gtr:id><gtr:impact>Our staff involved have presented the results of thesew studies at various international meetings

More Unit visibility and recognition. We are now collaborating with other partners working in related areas</gtr:impact><gtr:outcomeId>gH9UqKC7sBa</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Conference presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4F23C87F-AC3A-4FB0-ABB3-62D993914AE3</gtr:id><gtr:impact>This was an international conference attended by many international delegates

Questions from audience</gtr:impact><gtr:outcomeId>dC2t5bKnWRz</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Present at ministry and media</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>5179F535-FF6F-43F4-A31D-2E0222B98EC0</gtr:id><gtr:impact>There was a lot of interest in our results showing that superinfection does occur and hence need to educate even those already infected.

This is changing the messages about prevention in the HIV positives</gtr:impact><gtr:outcomeId>RwW4APSAQNT</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EDCTP</gtr:description><gtr:end>2009-01-02</gtr:end><gtr:fundingOrg>World Health Organization (WHO)</gtr:fundingOrg><gtr:id>D0AAA11F-35B0-4737-8925-F76D86385827</gtr:id><gtr:outcomeId>ZXXVDikdnSg0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>EDCTP</gtr:description><gtr:end>2009-03-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>A644901C-8C59-4BFE-93ED-00C94ED19A15</gtr:id><gtr:outcomeId>ZXXVDikdnSg1</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>998BE780-686E-448F-B799-E63AE4A56D3E</gtr:id><gtr:title>Multiple HIV-1 infections with evidence of recombination in heterosexual partnerships in a low risk Rural Clinical Cohort in Uganda.</gtr:title><gtr:parentPublicationTitle>Virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65a9eea965e9c3dad2ff04c4f72830d"><gtr:id>d65a9eea965e9c3dad2ff04c4f72830d</gtr:id><gtr:otherNames>Ssemwanga D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0042-6822</gtr:issn><gtr:outcomeId>EgvmyUn94dh</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2CED17BB-814C-4E24-8F26-08D1CDEDF41A</gtr:id><gtr:title>HIV type 1 subtype distribution, multiple infections, sexual networks, and partnership histories in female sex workers in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>AIDS research and human retroviruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d65a9eea965e9c3dad2ff04c4f72830d"><gtr:id>d65a9eea965e9c3dad2ff04c4f72830d</gtr:id><gtr:otherNames>Ssemwanga D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0889-2229</gtr:issn><gtr:outcomeId>J5NRe3Z1zGN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF06A1D8-4EDC-4B12-8244-FBF811B16976</gtr:id><gtr:title>HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies.</gtr:title><gtr:parentPublicationTitle>Vaccine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c4ac075a6de4679b80ef146ceae513"><gtr:id>40c4ac075a6de4679b80ef146ceae513</gtr:id><gtr:otherNames>Serwanga J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0264-410X</gtr:issn><gtr:outcomeId>5aa912c951db02.69745335</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U950092728</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>9A8BEDCC-D902-4C9A-8CCF-C974265EA3FB</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.4  Surveillance and distribution</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>